Results 121 to 130 of about 67,725 (254)

Dimensionality of the system usability scale among professionals using internet-based interventions for depression: a confirmatory factor analysis. [PDF]

BMC Psychiatry, 2020
Mol M, van Schaik A, Dozeman E, Ruwaard J, Vis C, Ebert DD, Etzelmueller A, Mathiasen K, Moles B, Mora T, Pedersen CD, Skjøth MM, Pensado LP, Piera-Jimenez J, Gokcay D, Ince BÜ, Russi A, Sacco Y, Zanalda E, Zabala AF, Riper H, Smit JH.   +21 more
europepmc   +1 more source

Evaluation of Travel App’s Usability Using the System Usability Scale Method

Scientific Journal of Informatics
Purpose: The objective of this study is to assess the usability of the Baraya Travel application, highlighting areas for enhancement to improve the online ticket booking experience for users. By concentrating on the Baraya Travel app as the research subject, the study intends to offer valuable insights for its developers.
Revi Raka Putra, Rahmat Yasirandi, Muhammad Mirza Qusyairi   +2 more
openaire   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Evaluation of usability of gas chromatography systems: Efficiency, Effectiveness and Satisfaction

Salāmat-i kār-i Īrān, 2014
Background and aims: Interface analysis methods are used to assess the man-machine interface of a particular system, product or device. Interface analysis methods can be used to assess a number of different aspects associated with a particular interface,
M Shekari, D Afshari
doaj  

PAON usability testing using system usability scale

Journal of Physics: Conference Series, 2019
K Setemen, L J Erawati Dewi, I K Purnamawan   +2 more
openaire   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

EVALUATING LABORATORY WEBSITE USABILITY THROUGH THE SYSTEM USABILITY SCALE (SUS)

JURTEKSI (Jurnal Teknologi dan Sistem Informasi)
Abstract: The Manual Drawing Laboratory and Computer Laboratory of the Furniture Design Study Program are some of the infrastructures used to support learning and practicum in the Polytechnic of Furniture Industry and Wood Processing. Services at these two laboratories utilize the Laboratory website which can be accessed publicly via the address https:/
Safarah Putri Ma'wa, Friska Damayanti, Niki Etruly   +2 more
openaire   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source